Strides Pharma Science LtdNSE: STAR

Press Release Jun 24 2022

· Issued by Strides Pharma Science Ltd

Filed with NSE · · 4 pages · English

On 6ix: 6ix.com/news/press-release-jun-24-2022-5

Release

Strides Pharma Science Limited has informed the Exchange about press release dated 24-Jun-2022 titled Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases